Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
Add more filters

Complementary Medicines
Country/Region as subject
Publication year range
1.
Heliyon ; 9(3): e14168, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36923824

ABSTRACT

Sonchus arvensisL. (SA) is a traditional Chinese food and medicine termed "Ju Mai Cai". The aim of this study was to investigate the protective effects of an aqueous extract of SA on dextran sulfate sodium (DSS) - induced colitis in mice by adjusting the diversity of gut microbiota. Male C57BL/6 mice were randomly divided into four groups: CL (control group); ML group (DSS only); SA group (SA extract); and MS group (SA extract + DSS). The protective effect of SA on ulcerative disease was estimated by several analyses (i.e., body weight loss, diarrhea, bloody stools, disease activity index scores, and hematoxylin and eosin staining). The effect of SA on gut microbiota was determined by analysis of the 16S ribosomal RNA gene sequences. The results indicated that MS significantly attenuated the body weight loss. The disease activity index scores were markedly lower in the MS group versus in the ML group. Moreover, the length of the colon was significantly improved in the MS groups versus in the ML group. Pathological changes were markedly improved following the administration of SA to mice with DSS-induced ulcerative disease. The results of Beta diversity analysis revealed that the composition of gut microbiota was significantly different between groups. Taken together, the results indicated that SA extract may prevent ulcerative colitis.

2.
Crit Rev Food Sci Nutr ; : 1-19, 2022 Sep 12.
Article in English | MEDLINE | ID: mdl-36094452

ABSTRACT

During the coronavirus disease 2019 (COVID-19) pandemic and continuing emergence of viral mutants, there has been a lack of effective treatment methods. Zinc maintains immune function, with direct and indirect antiviral activities. Zinc nutritional status is a critical factor in antiviral immune responses. Importantly, COVID-19 and zinc deficiency overlap in high-risk population. Hence, the potential effect of zinc as a preventive and adjunct therapy for COVID-19 is intriguing. Here, this review summarizes the immune and antiviral function of zinc, the relationship between zinc levels, susceptibility, and severity of COVID-19, and the effect of zinc supplementation on COVID-19. Existing studies have confirmed that zinc deficiency was associated with COVID-19 susceptibility and severity. Zinc supplementation plays a potentially protective role in enhancing immunity, decreasing susceptibility, shortening illness duration, and reducing the severity of COVID-19. We recommend that zinc levels should be monitored, particularly in COVID-19 patients, and zinc as a preventive and adjunct therapy for COVID-19 should be considered for groups at risk of zinc deficiency to reduce susceptibility and disease severity.

3.
Cell Metab ; 33(10): 1908-1910, 2021 10 05.
Article in English | MEDLINE | ID: mdl-34614407

ABSTRACT

The significant transformation of dietary patterns in China has contributed to an increasing prevalence of type 2 diabetes over the past few decades. In this article, we comprehensively summarize the epidemiological characteristics of diabetes in China and further discuss major nutritional risk factors for diabetes. Although China has committed to combat diabetes through health system reform and national initiatives, the burden of diabetes remains a major challenge, with an increased premature mortality for the population. We therefore provide several recommendations for the nation's future diabetes agenda, with the aim of establishing an environment of healthy nutrition through multi-sectoral government and community engagement, and novel, robust scientific research.


Subject(s)
Diabetes Mellitus, Type 2 , China/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/prevention & control , Humans , Nutritional Status , Risk Factors
4.
Ann Med ; 53(1): 1744-1757, 2021 12.
Article in English | MEDLINE | ID: mdl-34672217

ABSTRACT

BACKGROUND: Associations of dietary or supplementary intake of several unsaturated fatty acids and mortality have been widely studied but the results were still hitherto inconsistent or limited. It is still need to explore the effects of these fatty acids by using the objective biomarkers. OBJECTIVE: We aimed to investigate the relevancy of several serum n-3 and n-6 fatty acids with all-cause and disease-specific mortality to confirm their health effects and effects on the associations between dietary quality and all-cause mortality. METHODS: A total of 4132 people from NHANES 2003-2004 and 2011-2012 and the mortality information was confirmed from the NDI. CPH models adjusted for known risk factors were conducted to explore the associations between circulating n-3 and n-6 fatty acids and all-cause or CVD or cancer mortality under complex sampling. We further evaluated their effects on association between dietary quality and all-cause mortality. RESULTS: A total of 437 deaths occurred during the mean follow-up of 83.34 months, including 157 CVD death and 100 cancer death. Serum LA, ALA, EPA and DHA were associated with all-cause mortality (HR in quintile5: LA:0.584, 95%CI: 0.387-0.882, Ptrend = 0.011; ALA:0.626, 95%CI: 0.432-0.907, Ptrend = 0.008; EPA:0.535, 95%CI: 0.375-0.764, Ptrend = 0.001; DHA:0.669, 95%CI: 0.468-0.955, Ptrend = 0.031). Additionally, serum EPA and ALA were respectively related to CVD and cancer mortality (Q5 HR: EPA:0.450, 95%CI: 0.23-0.854, Ptrend = 0.009; ALA:0.387, 95%CI: 0.167-0.900, Ptrend = 0.022). Serum AA, GLA, DGLA and SDA were not associated with any risk of mortality. The effect on all-cause mortality of the lower AHEI scores can be improved by adherence to a higher serum LA, EPA and DHA (in the lowest AHEI strata, LA in tertile3 compared to tertile1 HR:0.596, 95%CI: 0.366-0.970; EPA:0.660, 95%CI: 0.454-0.959; DHA:0.666, 95%CI; 0.444-1.000). CONCLUSIONS: Our results support the recent dietary recommendations to increase the intake of plant-derived and marine-derived n-6 and n-3 to improve the ability of primary and secondary prevention.


Subject(s)
Fatty Acids, Omega-3/blood , Fatty Acids, Omega-6/blood , Fatty Acids, Unsaturated/blood , Mortality , Biomarkers/blood , Cardiovascular Diseases/blood , Cardiovascular Diseases/mortality , Diet Records , Humans , Neoplasms/blood , Neoplasms/mortality , Nutrition Surveys , Risk Assessment
5.
BMC Cancer ; 21(1): 912, 2021 Aug 11.
Article in English | MEDLINE | ID: mdl-34380458

ABSTRACT

BACKGROUND: Intake time of diet has recently been demonstrated to be associated with the internal clock and circadian pattern. However, whether and how the intake time of minerals would influence the natural course of cancer was largely unknown. METHODS: This study aimed to assess the association of mineral intake at different periods with cancer and all-cause mortality. A total of 27,455 participants aged 18-85 years old in the National Health and Nutrition Examination Survey were recruited. The main exposures were the mineral intakes in the morning, afternoon and evening, which were categorized into quintiles, respectively. The main outcomes were mortality of cancer and all causes. RESULTS: During the 178,182 person-years of follow-up, 2680 deaths, including 601 deaths due to cancer, were documented. After adjusting for potential confounders, compared to the participants who were in the lowest quintile(quintile-1) of mineral intakes at dinner, the participants in the highest quintile intake(quintile-5) of dietary potassium, calcium and magnesium had lower mortality risks of cancer (HRpotassium = 0.72, 95% CI:0.55-0.94, P for trend = 0.023; HRcalcium = 0.74, 95% CI:0.57-0.98, P for trend = 0.05; HRmagnesium = 0.75, 95% CI:0.56-0.99, P for trend = 0.037) and all-cause (HRpotassium = 0.83, 95% CI:0.73-0.94, P for trend = 0.012; HRcalcium = 0.87, 95% CI:0.76-0.99, P for trend = 0.025; HRmagnesium = 0.85, 95% CI:0.74-0.97, P for trend = 0.011; HRcopper = 0.80, 95%CI: 0.68-0.94, P for trend = 0.012). Further, equivalently replacing 10% of dietary potassium, calcium and magnesium consumed in the morning with those in the evening were associated with lower mortality risk of cancer (HRpotassium = 0.94, 95%CI:0.91-0.97; HRcalcium = 0.95, 95%CI:0.92-0.98; HRmagnesium = 0.95, 95%CI: 0.92-0.98). CONCLUSIONS: This study demonstrated that the optimal intake time of potassium, calcium and magnesium for reducing the risk of cancer and all-cause mortality was in the evening.


Subject(s)
Dietary Supplements , Meals , Minerals/administration & dosage , Neoplasms/epidemiology , Adult , Aged , Aged, 80 and over , Cause of Death , Female , History, 21st Century , Humans , Male , Middle Aged , Neoplasms/history , Neoplasms/mortality , Nutrition Surveys , Nutritional Status , Proportional Hazards Models , Risk Factors , United States/epidemiology
6.
Clin Nutr ; 40(5): 2683-2696, 2021 05.
Article in English | MEDLINE | ID: mdl-33933734

ABSTRACT

BACKGROUND: Zinc deficiency is a worldwide public health problem. Currently, there are no established biomarkers available for the accurate diagnosis of zinc-deficiency in individuals. Additionally, a comprehensive view of the adverse effects of zinc deficiency is lacking. Our aim was to identify superior biomarkers of zinc deficiency and uncover the adverse effects of zinc deficiency. METHODS: We performed multi-omics analysis using serum proteomics-metabolomics and liver proteomics on zinc-deficient rats to identify candidate biomarkers and reveal the associated adverse effects of zinc deficiency. Secondly, the candidate biomarkers were validated in two zinc-deficient populations and an RCT zinc supplementation trial on a zinc-deficient population. RESULTS: Our integrated multi-omics approach revealed numerous biomarkers (>2000) and glutathione metabolism as the most important changed pathway in zinc deficiency. Three candidate biomarkers from glutathione metabolism were validated in repeated zinc-deficient rats by quantitative analysis. Only glutathione sulfotransferase omega-1 (GSTO1) (among 3 candidate biomarkers) was validated in the two zinc-deficient populations and zinc-supplemented population. Compared with serum zinc, serum GSTO1 yielded a better response to zinc supplementation and a higher correlation coefficient with zinc intake and the AUC value and has the potential for diagnosing zinc deficiency. By integrated multi-omics, we identified both established and novel adverse effects of zinc deficiency. CONCLUSIONS: Our integrated multi-omics analysis revealed more complete information about zinc deficiency; GSTO1 was found to be a reliable potential biomarker for diagnosis of zinc deficiency. This trial is registered at http://www.chictr.org.cn/registry.aspx as ChiCTR1900028162.


Subject(s)
Metabolomics/methods , Proteomics/methods , Zinc/deficiency , Adult , Animals , Biomarkers/blood , Child , Child, Preschool , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Humans , Male , Middle Aged , Proteins/genetics , Proteins/metabolism , Rats , Rats, Sprague-Dawley , Zinc/metabolism
7.
Wei Sheng Yan Jiu ; 50(2): 279-283, 2021 Mar.
Article in Chinese | MEDLINE | ID: mdl-33985637

ABSTRACT

OBJECTIVE: To investigate the effects of calcium supplementation on the inflammatory response of vascular endothelial cells and the possible role and mechanism of G protein-coupled estrogen receptor(GPER)under the physiological conditions of estrogen deficiency(ovary removal). METHODS: Forty healthy 8-week-old female C57 BL/6 mice were divided into 4 groups by random number table according to body weight, which were respectively the control group, ovarian removal group, ovarian removal high calcium group, and G1 ovarian removal high calcium group, each group ten. One week after the basal diet, the control group underwent sham surgery, and the ovaries-removed group, ovarian-removed high-calcium group, and G1 ovarian-removed high-calcium group were treated for ovarian removal. The control group and the ovary-removed group were fed basic feed(AIN-93 G, calcium content 0. 5%), the ovarian-removed high-calcium group and the G1 implanted ovarian-removed high-calcium group were fed high-calcium feed(adjusted AIN-93 G, calcium content 1. 5%). Three months later, mice in the control, ovarian-removed, and ovarian-reduced high-calcium groups were implanted with a placebo subcutaneously, and G1 ovarian-removed high-calcium groups were implanted with a GPER specific agonist G1, intervention for 28 days, under the anesthesia state, collect blood from 40 mice, isolate serum to measure vascular endothelial adhesion factor-1(VCAM-1), tumor necrosis factor-α(TNF-α), estradiol and blood calcium concentration; take aortic arch for immunization histochemical detection of transient receptor potential channel 1(TRPC1), phosphorylated-extracellular regulated kinase(p-ERK)1/2, VCAM-1 and CD68 expression levels. SPSS software performs statistical analysis and draws conclusion. RESULTS: The differences in weight gain between the three groups and the control group were statistically significant(P<0. 05), while the differences in weight between the three groups were not statistically significant(P>0. 05). There were statistically significant differences in serum estradiol levels between the three groups, the ovariectomized high calcium group, and the G1 ovariectomized group implanted with the control group(P<0. 05). The difference was not statistically significant(P>0. 05). The differences in serum VCAM-1 concentrations between the control group and the other three groups were statistically significant(P<0. 05). The difference in serum VCAM-1 concentration was statistically significant between the ovariectomized group and the implanted G1 ovariectomized high calcium group and the ovariectomized high calcium group(P<0. 05). There was no significant difference in serum VCAM-1 concentration in the group(P>0. 05). There was no significant difference in TNF-α concentration between the four groups(P>0. 05). By immunohistochemistry, the percentages of TRPC1, p-ERK1/2, VCAM-1, and CD68-positive cell areas in the ovarian high-calcium group were significantly higher than those in the ovarian-removed group and the G1-ovarian-removed high-calcium group. The difference was statistically significant(P<0. 05), and the difference in the percentage of positive cell area between the ovarian-removed group and the G1-removed high-calcium group was not statistically significant(P>0. 05). CONCLUSION: In the state of estrogen deficiency, calcium supplementation causes an increase in inflammatory response, which may be related to the change in GPER activity, and then affect the TRPC1/ERK1/2 pathway.


Subject(s)
Endothelial Cells , Receptors, Estrogen , Animals , Estradiol , Estrogens , Female , GTP-Binding Proteins , Humans , Mice , Ovariectomy , Receptors, Estrogen/metabolism
8.
Aging (Albany NY) ; 13(4): 5571-5584, 2021 02 11.
Article in English | MEDLINE | ID: mdl-33589569

ABSTRACT

Both excessive energy intake and low calcium intake are inversely associated with the aging-related diseases, particularly for type 2 diabetes mellitus(T2DM). This study examined whether energy reduction coupled with calcium supplementation aided in the prevention of T2DM among the overweight population. A randomized controlled trial(RCT) of 1021 overweight participants was performed, in which participants were randomly assigned to 4 groups: 1) energy-reduction group(ERG), 2) calcium supplementation group(CSG), 3) energy-reduction with calcium supplementation group(ER-CSG), 4) control group(CG). Nutritional habits, anthropometric and diabetes-related indicators were measured at baseline and each follow-up time. To analyze the separate effects of dietary energy reduction and calcium supplementation, ERG and ER-CSG were integrated into ERGs. Similarly, CSG and ER-CSG were integrated into CSGs. Compared to the non-energy-reduction groups(NERGs), ERGs had lower values of ΔBMI(-0.9kg/m2), ΔFSG (-0.34mmol/L), ΔHbA1c(0.16%), and ΔHOMA-IR(-0.13), and higher value of ΔGutt index(-5.82). Compared to the non-calcium supplementation groups(NCSGs), the ΔGutt index(-5.46) in CSGs showed a significant decrease. Moreover, these risk factors for T2DM were most effectively ameliorated in ER-CSG group with the decreased values of ΔFSG(-0.42mmol/L), ΔGutt index(-0.73), and the slowest increasing rate value of Δ2h-glucose(0.37mmol/L). This RCT demonstrated that energy-reduction with calcium supplementation was a useful dietary intervention strategy for preventing the development of T2DM in the overweight population.


Subject(s)
Calcium-Regulating Hormones and Agents/administration & dosage , Calcium/administration & dosage , Diabetes Mellitus, Type 2/prevention & control , Diet, Reducing/statistics & numerical data , Overweight/diet therapy , Adult , Blood Glucose , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diet therapy , Dietary Supplements , Female , Glycated Hemoglobin/metabolism , Humans , Insulin Resistance , Male , Middle Aged , Overweight/blood , Overweight/complications , Patient Compliance
9.
Clin Nutr ; 40(4): 2401-2409, 2021 04.
Article in English | MEDLINE | ID: mdl-33143929

ABSTRACT

BACKGROUND & AIMS: Although disorders of iron metabolism are among the most common diseases and dietary intakes of vitamin A, B2, B6, C, E, and folic acid are known to affect the absorption or oxidation of iron, limited data are available on the association of dietary iron and these vitamins with mortality in the same population. Specifically, the holistic dietary vitamins intake and its combined effect with iron on mortality are unclear. The purpose of this study was to evaluate the association of dietary iron, holistic dietary vitamins, and their interactive effect with total and cause-specific mortality. METHODS: We evaluated the effects of dietary total/heme/non-heme iron, vitamins, and their interaction on all-cause/cardiovascular disease (CVD)/cancer mortality among 14,826 US adults in the National Health and Nutrition Examination Survey (NHANES), a population-based nationally representative study. We developed a vitamin score to represent the holistic dietary intakes of vitamin A, B2, B6, C, E, and folic acid. RESULTS: A total of 2154 deaths occurred during a median follow-up of 9.3 years. Results from multivariate Cox proportional hazards models showed that higher vitamin score was associated lower risk of all-cause mortality (P-trend = 0.027). Negative interactions between dietary heme iron and vitamin score were observed on all-cause/CVD mortality. Dietary higher vitamins combined with lower heme iron was associated with lower risk of all-cause and CVD mortality (HR (95% confidence intervals (CIs)): 0.80 (0.64-0.98) and 0.55 (0.31-0.98), respectively). Higher dietary vitamins combined with higher total/non-heme iron was associated with lower risk of CVD mortality (HR (95%CIs): 0.69 (0.48-0.99) and 0.70 (0.48-0.99), respectively). These results remained significant even excluding participants with iron supplementation. CONCLUSION: Our findings suggested that interactive effect of holistic dietary vitamins and iron play a protective role in decreasing all-cause and CVD mortality. Future studies, including cohort studies and clinical trials, are necessary to confirm these findings.


Subject(s)
Diet , Iron, Dietary , Mortality , Vitamins , Adult , Cardiovascular Diseases/mortality , Female , Humans , Male , Middle Aged , Nutrition Surveys , Proportional Hazards Models
10.
Clin Nutr ; 40(2): 476-487, 2021 02.
Article in English | MEDLINE | ID: mdl-32571678

ABSTRACT

BACKGROUND & AIMS: Maternal folic acid (FA) supplement (FolS) programs the early development of an offspring. The onset of complex diseases at a later stage of life has been evidently linked with maternal FA ingestion. However, little is known regarding the underlying molecule fingerprints of the offspring. Here, we analyze the influence of maternal FolS on the metabolism of the adult offspring rats using the integrated metabolomics-proteomics. METHODS: Twenty pregnant female rats were randomly assigned to a FA supplement (FolS group) or control group which were fed AIN93G diet with 2 or 5 mg/kg FA, respectively. The blood samples from the offspring at 0, 3 and 7 weeks after birth were collected. The brain samples were obtained from the offspring at 7 weeks after birth. Serum and brain metabolite profiles were performed by UPLC-MS/MS and the brain proteomics analysis was obtained using iTRAQ-based quantitative proteomics. RESULTS: The metabolic change of the offspring for the maternal FA supplement is characterized by the phospholipids, fatty acid and amino acids, which are involved in linoleic acid, docosahexaenoic acid, glycerophosphocholine, lysophosphatidylcholine, tryptophan, glycine, arachidonic acid, γ-aminobutyric acid, and so on. Using iTRAQ-based quantitative proteomics analysis, 51 differential proteins in the brain are identified, which provides valuable insight into the underlying mechanisms of the offspring after the maternal FolS. These results demonstrate neural development related metabolites and proteins, such as docosahexaenoic acid, glycine, tryptophan, γ-aminobutyric acid, dopaminergic synapse related proteins including G protein, PPP1R1B and CAMK2G, are significantly altered, which suggests that the active neural conduction occurs in the offspring after maternal FA supplement. The behavioral testing demonstrates that the high level of memory is observed in rats with FA supplement. CONCLUSIONS: We conceive that the alterations of metabolites and protein in the offspring are associated with the maternal FA supplement and these alterations are involved in the neural development, although such animal data are limited in their ability to mimic metabolic outcomes in humans.


Subject(s)
Animal Nutritional Physiological Phenomena/physiology , Dietary Supplements , Folic Acid/administration & dosage , Maternal Nutritional Physiological Phenomena/physiology , Neurogenesis/physiology , Animals , Behavior, Animal , Brain/metabolism , Chromatography, Liquid , Female , Metabolomics , Pregnancy , Prenatal Care , Prenatal Exposure Delayed Effects/prevention & control , Proteomics , Rats , Tandem Mass Spectrometry
11.
Biomed Res Int ; 2020: 8058463, 2020.
Article in English | MEDLINE | ID: mdl-32076615

ABSTRACT

The relationship between selenium (Se) and type 2 diabetes (T2D) remains controversial. In previous animal and cell studies, Se was found to be insulin mimic and antidiabetic, whereas recent epidemiological and interventional trials have shown an unexpected association between high Se intake and increased risk of T2D. The present study aimed to investigate the significance of dietary Se and T2D in North Chinese adults. A large sample of the population was enrolled through cluster sampling in Northern China (N=8824). Information on basic characteristics, anthropometric measures, and dietary Se intake was collected from each subject for analysis. Multivariable logistic regression was used to investigate the association between dietary Se and T2D through adjusted odds ratio (OR) and the corresponding 95% confidence interval (CI). The average nutritional Se intake was 52.43 µg/day, and the prevalence of T2D was 20.4% in the studied population. The OR for developing T2D was 1.66 (95% CI: 1.38, 1.99; P for linear trend <0.005), comparing the highest to the lowest quintile of energy-adjusted Se intake in multivariate logistic regression analysis. The mediation analysis discovered that glucose metabolism (indicated by FBG and HbA1c) mediated this association. In conclusion, our research adds further support to the role of high dietary Se in the incidence of T2D. The results also suggested that this association was mediated by glucose metabolism.


Subject(s)
Diabetes Mellitus, Type 2/epidemiology , Diet , Nutritional Status , Selenium/adverse effects , Adult , Asian People , China/epidemiology , Cohort Studies , Cross-Sectional Studies , Energy Intake , Female , Humans , Incidence , Insulin , Logistic Models , Male , Middle Aged , Odds Ratio , Prevalence , Surveys and Questionnaires
12.
Biomed Chromatogr ; 34(3): e4765, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31778577

ABSTRACT

The aim of the present study was to develop a novel ultrasound-assisted derivatization method for analysis of urine that can be used for preliminary screening and monitoring of metabolic disorders. Here we describe an ultrasound-assisted derivatization method followed by GC-MS analysis to quantify 26 organic acids in urine. The optimum levels of the variables affecting the yield of derivatization were investigated, including urease doses, derivatization reagents and derivatization conditions (duration time, reaction temperature and sonic power). The method exhibited the best results with 80 µl urease. The optimal reaction conditions were 100 µl BSTFA, 80% ultrasound power, 70°C and 40 min. This method showed satisfactory linearity, good reproducibility and an acceptable limit of detection and accuracy. Therefore, it could potentially be used to as a standard method to enable comparisons between laboratories. Finally, we applied our method to urine samples from pregnant rats administered 2 or 10 mg/kg folic acid supplementation.


Subject(s)
Carboxylic Acids/urine , Gas Chromatography-Mass Spectrometry/methods , Metabolomics/methods , Sonication/methods , Animals , Female , Limit of Detection , Linear Models , Male , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Urease
13.
J Appl Toxicol ; 39(3): 441-450, 2019 03.
Article in English | MEDLINE | ID: mdl-30325046

ABSTRACT

This study aimed to investigate the nephrotoxicity in rats administered with chronic low-dose cadmium (Cd) by ultra-performance liquid chromatography-mass spectrometry. A total of 40 male Sprague-Dawley rats were randomly assigned to four groups, namely: control; low-dose (0.13 mg/kg·body weight [bw]); middle-dose (0.80 mg/kg·bw); and high-dose (4.89 mg/kg·bw). The rats received CdCl2 daily via drinking water for 24 weeks. Rat kidneys were collected for metabonomics analysis. Principal components analysis and partial least-squares discriminant analysis were used to investigate the metabonomics profile changes in the kidney samples and to screen the potential biomarkers. Ten metabolites were identified in the positive and negative ion modes. Compared with the control group, the intensities of tetranor 12-HETE, uric acid, hypoxanthine, phenylacetylglycine, guanidinosuccinic acid and xanthosine significantly increased (P < 0.01), and those of imidazolelactic acid, lactose 6-phosphate, l-urobilinogen and arachidonic acid significantly decreased (P < 0.01) in the high-dose group. Results showed that exposure to Cd in rats induced oxidative stress to the kidneys and disrupted amino acid metabolism, fatty acid metabolism and energy metabolism.


Subject(s)
Cadmium/toxicity , Kidney/drug effects , Metabolomics , Animals , Cadmium/metabolism , Chromatography, High Pressure Liquid/methods , Kidney/metabolism , Kidney/pathology , Male , Mass Spectrometry/methods , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley
14.
Article in English | MEDLINE | ID: mdl-29803868

ABSTRACT

Maternal diet during pregnancy can influence offspring's health by affecting development and metabolism. This study aimed to analyze the influence of maternal folic acid (FA) supplementation on the metabolism of rat pups using targeted metabolomics. Twenty female rats were randomly assigned to a FA supplementation (FAS group, n = 10) or control group (n = 10), which were fed AIN93G diet with 2 or 10 mg/kg FA, respectively. We then measured amino acids and their derivatives, biogenic amines, and fatty acids in the female rats and their pups by ultra-high performance liquid chromatography-triple quadrupole mass spectrometry (UHPLC/MS-MS) and gas chromatography-mass spectrometry (GC/MS-MS). In maternal rats, the significant changes of three metabolites (proline, γ-aminobutyric acid and esterified octadecatetraenoic acid, P < 0.05) were observed in FAS group. For the rat pups, FAS pups had significantly lower homocysteine and higher FA levels than control pups. The lower levels of amino acids (leucine, isoleucine, serine, proline) were obtained in FAS pups. Furthermore, there were the decreased esterified fatty acids (arachidonic acid, eicosapentaenoic acid, and docosatetraenoic acid) and free fatty acids (oleic acid, linoleic acid, γ-linolenic acid, octadecatetraenoic acid, arachidonic acid, eicosapentaenoic acid and selacholeic acid) in FAS pups. Metabolic changes in the FAS pups were characterized by changes in fatty acids and amino acids. These results suggested that FA supplementation during pregnancy influenced amino acids and fatty acids metabolism in rat pups. This study provides new insights into the regulation of amino acids and fatty acids metabolism during early life.


Subject(s)
Amino Acids/metabolism , Fatty Acids, Nonesterified/metabolism , Folic Acid/pharmacology , Metabolome/drug effects , Amino Acids/blood , Animals , Animals, Newborn/blood , Animals, Newborn/metabolism , Fatty Acids, Nonesterified/blood , Female , Folic Acid/administration & dosage , Folic Acid/therapeutic use , Gas Chromatography-Mass Spectrometry , Metabolomics , Pregnancy , Principal Component Analysis , Rats , Tandem Mass Spectrometry
15.
BMC Nutr ; 4: 12, 2018.
Article in English | MEDLINE | ID: mdl-32153876

ABSTRACT

BACKGROUND: The aims of the current study were to assess the nutritional status of 25OHD3 and retinol in a northern Chinese population using our established reliable method for the simultaneous determination of serum 25OHD3 and retinol. METHOD: We established a reliable method for the simultaneous determination of 25OHD3 and retinol using SPE and UPLC/PDA; measured the serum levels of 25OHD3 and retinol in elementary school students, middle school students, and adults (n = 1181) in northern China; and assessed their nutritional status. RESULTS: Our method had good precision, detection limit, and linear quantitative range and could process 100 samples within 12 h. The average levels of 25OHD3 and retinol were 16.1 ± 6.7 ng/ml and 328.1 ± 117.1 ng/ml, respectively, in all samples. VD deficiency was common, with a prevalence > 60% in all three age groups, and the high prevalence of VA deficiency (26.1%) was observed only in the elementary school students. CONCLUSIONS: Vitamin A supplementation should be considered for elementary school students, and vitamin D supplementation is highly recommended for all age groups in Harbin. Our method could be widely adopted in population-based studies and clinical practice.

16.
Nutrients ; 9(9)2017 Aug 26.
Article in English | MEDLINE | ID: mdl-28846595

ABSTRACT

The effects of maternal prenatal folic acid supplementation (FAS) on offspring lipid metabolism in adulthood remains unclear, although prenatal FAS is compulsively suggested in many countries. Female Sprague-Dawley rats were fed with control (CON) or FAS diets before and during pregnancy. Male offspring of CON and FAS dams were further divided into two groups at seven weeks for CON and high-fat (HF) diet interventions for eight weeks in adulthood (n = 10). The interactive effects of maternal prenatal FAS and offspring HF in adulthood on lipid metabolism and DNA methylation of genes involved in lipids metabolism were assessed. The male offspring of FAS dams had elevated serum and liver triglyceride level when fed with HF compared to the male offspring of CON dams. The mRNA and protein expression levels of hepatic ATGL and adipose LPL were significantly decreased in offspring of FAS dams than in offspring of CON dams. Furthermore, maternal prenatal FAS resulted in elevated DNA methylation levels in the promoter and first exon region of hepatic ATGL and adipose LPL in offspring. Maternal FAS exacerbated the adverse effects of HF on lipid metabolism in offspring through inducing aberrant DNA methylation levels of hepatic ATGL and adipose LPL.


Subject(s)
DNA Methylation , Dietary Supplements/adverse effects , Folic Acid/adverse effects , Lipase/metabolism , Lipoprotein Lipase/metabolism , Liver/metabolism , Maternal Nutritional Physiological Phenomena , Animals , Biomarkers/blood , Biomarkers/metabolism , Diet, High-Fat/adverse effects , Epigenesis, Genetic , Exons , Female , Gene Expression Regulation, Developmental , Hyperlipidemias/blood , Hyperlipidemias/etiology , Hyperlipidemias/metabolism , Lipase/genetics , Lipid Metabolism , Lipoprotein Lipase/genetics , Liver/enzymology , Male , Pregnancy , Promoter Regions, Genetic , Random Allocation , Rats, Sprague-Dawley , Weaning
17.
J Proteome Res ; 16(6): 2221-2230, 2017 06 02.
Article in English | MEDLINE | ID: mdl-28447460

ABSTRACT

The aim of current study was to investigate the metabolic changes associated with histidine supplementation in serum and urine metabolic signatures and serum amino acid (AA) profiles. Serum and urine 1H NMR-based metabolomics and serum AA profiles were employed in 32 and 37 obese women with metabolic syndrome (MetS) intervened with placebo or histidine for 12 weeks. Multivariable statistical analysis were conducted to define characteristic metabolites. In serum 1H NMR metabolic profiles, increases in histidine, glutamine, aspartate, glycine, choline, and trimethylamine-N-oxide (TMAO) were observed; meanwhile, decreases in cholesterol, triglycerides, fatty acids and unsaturated lipids, acetone, and α/ß-glucose were exhibited after histidine supplement. In urine 1H NMR metabolic profiles, citrate, creatinine/creatine, methylguanidine, and betaine + TMAO were higher, while hippurate was lower in histidine supplement group. In serum AA profiles, 10 AAs changed after histidine supplementation, including increased histidine, glycine, alanine, lysine, asparagine, and tyrosine and decreased leucine, isoleucine, ornithine, and citrulline. The study showed a systemic metabolic response in serum and urine metabolomics and AA profiles to histidine supplementation, showing significantly changed metabolism in AAs, lipid, and glucose in obese women with MetS.


Subject(s)
Histidine/pharmacology , Metabolome/drug effects , Adult , Amino Acids/blood , Amino Acids/drug effects , Amino Acids/metabolism , Blood Glucose/drug effects , Blood Glucose/metabolism , Dietary Supplements , Female , Histidine/administration & dosage , Humans , Lipid Metabolism/drug effects , Metabolic Syndrome/drug therapy , Metabolic Syndrome/metabolism , Middle Aged , Obesity/metabolism , Proton Magnetic Resonance Spectroscopy , Serum/chemistry , Urine/chemistry
18.
Xenobiotica ; 47(5): 439-449, 2017 May.
Article in English | MEDLINE | ID: mdl-27347750

ABSTRACT

1. To study the toxic effect of chronic exposure to acrylamide (AA) at low-dose levels, we applied metabolomics approach based on ultra-performance liquid chromatography/mass spectrometry (UPLC-MS). A total of 40 male Wistar rats were randomly assigned to different groups: control, low-dose AA (0.2 mg/kg.bw), middle-dose AA (1 mg/kg.bw) and high-dose AA (5 mg/kg.bw). The rats continuously received AA via drinking water for 16 weeks. Rat urine samples were collected at different time points for measurement of metabolomic profiles. 2. Thirteen metabolites, including the biomarkers of AA exposure (AAMA, GAMA and iso-GAMA), were identified from the metabolomic profiles of rat urine. Compared with the control group, the treated groups showed significantly increased intensities of GAMA, AAMA, iso-GAMA, vinylacetylglycine, 1-salicylate glucuronide, PE (20:1(11Z)/14:0), cysteic acid, L-cysteine, p-cresol sulfate and 7-ketodeoxycholic acid, as well as decreased intensities of 3-acetamidobutanal, 2-indolecarboxylic acid and kynurenic acid in rat urine. Notably, three new candidate biomarkers (p-cresol sulfate, 7-ketodeoxycholic acid and 1-salicylate glucuronide) in rat urine exposed to AA have been found in this study. 3. The results indicate exposure to AA disrupts the metabolism of lipids and amino acids, induces oxidative stress.


Subject(s)
Acrylamide/urine , Hazardous Substances/urine , Acrylamide/toxicity , Amino Acids/metabolism , Animals , Biomarkers/urine , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Hazardous Substances/toxicity , Lipid Metabolism/drug effects , Male , Mass Spectrometry , Metabolome/drug effects , Metabolomics , Random Allocation , Rats , Rats, Wistar , Toxicity Tests, Chronic
19.
Diabetes Metab Res Rev ; 32(1): 2-10, 2016 Jan.
Article in English | MEDLINE | ID: mdl-25689396

ABSTRACT

As consumption of tea has been confirmed as a protective factor for type 2 diabetes mellitus (T2DM), it would be interesting to know if T2DM patients could benefit from tea. Because of small sample sizes and inconsistent results of previous studies, we performed this meta-analysis to reevaluate the effects of tea or tea extract on all available outcomes in patients with T2DM. We systematically searched electronic databases of PubMed, Cochrane Library and EMBASE to identify randomized controlled trials of tea in T2DM patients up to January 2015. Weight mean differences for the changes in all outcomes were pooled by Review Manager 5.2 (Cochrane Collaboration, Oxford, England). A total of ten trials including 608 subjects were identified. The meta-analysis found that tea could alleviate the decrease of fasting blood insulin [1.30 U/L, 95% CI (0.36, 2.24)], and reduced waist circumference only in more than 8-week intervention [-2.70 cm, 95% CI (-4.72, -0.69)], whereas there were no statistically significant differences with regard to homeostasis model of insulin resistance 0.38 (-0.18, 0.95), fasting blood glucose -0.05 mmol/L (-0.51, 0.40), low density lipoprotein-cholesterol 0.07 mmol/L (-0.15, 0.29), high density lipoprotein-cholesterol 0.01 mmol/L (-0.08, 0.09), body mass index -0.15 kg/m(2) (-0.50, 0.21), SBP 0.35 mmHg (-3.54, 4.24), DBP -1.02 mmHg (-3.53, 1.48), triglycerides -0.11 mmol/L (-0.28, 0.05) and fasting cholesterol -0.05 mmol/L (-0.20, 0.11) in patients with T2DM, and leptin, ADPN, CRE and UA were also non-significant. The intervention of tea or tea extraction could maintain a stable fasting blood insulin and reduce waist circumference in the T2DM patients; however, the effects on other outcomes were not significant. Copyright © 2015 John Wiley & Sons, Ltd.


Subject(s)
Appetite Regulation , Camellia sinensis/chemistry , Diabetes Mellitus, Type 2/diet therapy , Dietary Supplements , Overweight/diet therapy , Plant Extracts/therapeutic use , Tea , Appetite Depressants/therapeutic use , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/metabolism , Diet, Diabetic , Diet, Reducing , Glycated Hemoglobin/analysis , Humans , Hyperglycemia/prevention & control , Hyperlipidemias/complications , Hyperlipidemias/prevention & control , Hypoglycemic Agents/therapeutic use , Insulin Resistance , Overweight/blood , Overweight/complications , Overweight/metabolism , Plant Leaves/chemistry , Randomized Controlled Trials as Topic , Waist Circumference , Weight Loss
20.
Mol Nutr Food Res ; 59(8): 1491-503, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25944715

ABSTRACT

SCOPE: Ursolic acid (UA) is a triterpenoid compound with multifold biological functions. Our previous studies have reported that UA protects against high-fat diet-induced obesity and improves insulin resistance (IR). However, the potential mechanisms are still undefined. Free fatty acid (FFA) metabolism in skeletal muscle plays a central role in obesity and IR. Therefore, in this study, we investigated the effect and the potential mechanisms of UA on skeletal muscle FFA metabolism. METHODS AND RESULTS: In diet-induced obese rats, 0.5% UA supplementation for 6 weeks markedly reduced body weight, increased energy expenditure, decreased FFA level in serum and skeletal muscle and triglyceride content in skeletal muscle. In vitro, the data provided directly evidence that UA significantly increased fluorescently labeled FFA uptake and (3) H-labeled palmitic acid ß-oxidation. UA-activated AMP-activated protein kinase (AMPK) and downstream targets were involved in the increase of FFA catabolism. Moreover, upregulated uncoupling protein 3 (UCP3) by UA contributed to AMPK activation via elevating adenosine monophosphate/adenosine triphosphate ratio. CONCLUSION: UA increases FFA burning through enhancing skeletal muscle FFA uptake and ß-oxidation via an UCP3/AMPK-dependent pathway, which provides a novel perspective on the biological function of UA against obesity and IR.


Subject(s)
Anti-Obesity Agents/therapeutic use , Dietary Supplements , Energy Metabolism , Fatty Acids, Nonesterified/metabolism , Ion Channels/agonists , Mitochondrial Proteins/agonists , Muscle, Skeletal/metabolism , Triterpenes/therapeutic use , AMP-Activated Protein Kinases/antagonists & inhibitors , AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/metabolism , Absorption, Physiological , Animals , Cell Line , Diet, High-Fat/adverse effects , Fatty Acids, Nonesterified/blood , Ion Channels/antagonists & inhibitors , Ion Channels/genetics , Ion Channels/metabolism , Male , Mice , Mitochondrial Proteins/antagonists & inhibitors , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Muscle, Skeletal/enzymology , Obesity/blood , Obesity/diet therapy , Obesity/etiology , Obesity/metabolism , RNA Interference , Random Allocation , Rats, Sprague-Dawley , Second Messenger Systems , Specific Pathogen-Free Organisms , Uncoupling Protein 3 , Ursolic Acid
SELECTION OF CITATIONS
SEARCH DETAIL